136 related articles for article (PubMed ID: 17332621)
1. Melanoma imaging with pretargeted bivalent bacteriophage.
Newton JR; Miao Y; Deutscher SL; Quinn TP
J Nucl Med; 2007 Mar; 48(3):429-36. PubMed ID: 17332621
[TBL] [Abstract][Full Text] [Related]
2. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
3. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.
Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP
J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional phage-based pretargeted imaging of human prostate carcinoma.
Newton-Northup JR; Figueroa SD; Quinn TP; Deutscher SL
Nucl Med Biol; 2009 Oct; 36(7):789-800. PubMed ID: 19720291
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2010 Mar; 51(3):418-26. PubMed ID: 20150256
[TBL] [Abstract][Full Text] [Related]
7. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
Miao Y; Benwell K; Quinn TP
J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
[TBL] [Abstract][Full Text] [Related]
8. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.
Kobayashi M; Kato T; Washiyama K; Ihara M; Mizutani A; Nishi K; Flores LG; Nishii R; Kawai K
PLoS One; 2019; 14(3):e0213397. PubMed ID: 30901323
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
11. 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.
Miao Y; Gallazzi F; Guo H; Quinn TP
Bioconjug Chem; 2008 Feb; 19(2):539-47. PubMed ID: 18197608
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.
Yang J; Guo H; Gallazzi F; Berwick M; Padilla RS; Miao Y
Bioconjug Chem; 2009 Aug; 20(8):1634-42. PubMed ID: 19552406
[TBL] [Abstract][Full Text] [Related]
14. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
15. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
16. A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.
Raposinho PD; Correia JD; Alves S; Botelho MF; Santos AC; Santos I
Nucl Med Biol; 2008 Jan; 35(1):91-9. PubMed ID: 18158948
[TBL] [Abstract][Full Text] [Related]
17. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
18. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
19. Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity.
Bapst JP; Froidevaux S; Calame M; Tanner H; Eberle AN
J Recept Signal Transduct Res; 2007; 27(5-6):383-409. PubMed ID: 18097939
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]